Ad5-RGD-D24-GMCSF

AXP000068.1 · Oncolytic virus

Platform
adenovirus (Ad5, RGD-modified fiber, Delta-24, GM-CSF-armed)
Originator
University of Helsinki (Akseli Hemminki)

Names

NameTypeSource
Ad5-RGD-D24-GMCSFpreferred name, codecurator, paper

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad5 (RGD fiber)
Replication
conditionally replicating
Modifications
Delta-24; RGD-4C motif in fiber HI loop
Transgenes
CSF2
Route
intratumoral, intraperitoneal, intrapleural, intravenous
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (0)

No trial in the latest ClinicalTrials.gov snapshot names this program.

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 21630267Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.International journal of cancer2012name in title: Ad5-RGD-D24-GMCSF

Notes

ATAP construct (2007-2012).

How to cite

Ad5-RGD-D24-GMCSF (AXP000068.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000068.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.